View in EDS

Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases.

Saved in:
Bibliographic Details
Title: Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases.
Authors: Bittner S; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Schmidleithner L; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Ruhland B; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Hofmann V; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Stüve P; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Hoffmann F; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Echtenacher B; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Hoffmann P; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany., Edinger M; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany., Beilhack A; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research (IZKF) Laboratory Würzburg, Center for Experimental Molecular Medicine, University Hospital Würzburg, 97078 Würzburg, Germany., Strieder N; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Hernandez-Lopez I; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany., Rehli M; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany., Hehlgans T; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Chair for Immunology, University Regensburg, 93053 Regensburg, Germany., Feuerer M; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Chair for Immunology, University Regensburg, 93053 Regensburg, Germany. Electronic address: markus.feuerer@ukr.de.
Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2026 Apr 01; Vol. 34 (4), pp. 2217-2235. Date of Electronic Publication: 2026 Jan 10.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41521559
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bittner+S%22">Bittner S</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmidleithner+L%22">Schmidleithner L</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Ruhland+B%22">Ruhland B</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hofmann+V%22">Hofmann V</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Stüve+P%22">Stüve P</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+F%22">Hoffmann F</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Echtenacher+B%22">Echtenacher B</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+P%22">Hoffmann P</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Edinger+M%22">Edinger M</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Beilhack+A%22">Beilhack A</searchLink>; Department of Internal Medicine II, Interdisciplinary Center for Clinical Research (IZKF) Laboratory Würzburg, Center for Experimental Molecular Medicine, University Hospital Würzburg, 97078 Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Strieder+N%22">Strieder N</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hernandez-Lopez+I%22">Hernandez-Lopez I</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Rehli+M%22">Rehli M</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hehlgans+T%22">Hehlgans T</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Chair for Immunology, University Regensburg, 93053 Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Feuerer+M%22">Feuerer M</searchLink>; Leibniz Institute for Immunotherapy (LIT), University Regensburg, 93053 Regensburg, Germany; Chair for Immunology, University Regensburg, 93053 Regensburg, Germany. Electronic address: markus.feuerer@ukr.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100890581%22">Molecular therapy : the journal of the American Society of Gene Therapy</searchLink> [Mol Ther] 2026 Apr 01; Vol. 34 (4), pp. 2217-2235. <i>Date of Electronic Publication: </i>2026 Jan 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100890581 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-0024 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215250016%22">15250016 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41521559
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ymthe.2026.01.002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2217
    Titles:
      – TitleFull: Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bittner S
      – PersonEntity:
          Name:
            NameFull: Schmidleithner L
      – PersonEntity:
          Name:
            NameFull: Ruhland B
      – PersonEntity:
          Name:
            NameFull: Hofmann V
      – PersonEntity:
          Name:
            NameFull: Stüve P
      – PersonEntity:
          Name:
            NameFull: Hoffmann F
      – PersonEntity:
          Name:
            NameFull: Echtenacher B
      – PersonEntity:
          Name:
            NameFull: Hoffmann P
      – PersonEntity:
          Name:
            NameFull: Edinger M
      – PersonEntity:
          Name:
            NameFull: Beilhack A
      – PersonEntity:
          Name:
            NameFull: Strieder N
      – PersonEntity:
          Name:
            NameFull: Hernandez-Lopez I
      – PersonEntity:
          Name:
            NameFull: Rehli M
      – PersonEntity:
          Name:
            NameFull: Hehlgans T
      – PersonEntity:
          Name:
            NameFull: Feuerer M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1525-0024
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Molecular therapy : the journal of the American Society of Gene Therapy
              Type: main
ResultId 1